These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Monoamine metabolites in CSF and suicidal behavior. Träskman L, Asberg M, Bertilsson L, Sjöstrand L. Arch Gen Psychiatry; 1981 Jun 17; 38(6):631-6. PubMed ID: 6166274 [Abstract] [Full Text] [Related]
10. The relationship between CSF HVA/5-HIAA ratio and suicide intent in suicide attempters. Jokinen J, Nordström AL, Nordström P. Arch Suicide Res; 2007 Jun 17; 11(2):187-92. PubMed ID: 17453696 [Abstract] [Full Text] [Related]
12. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method. Vanderheyden JE, Noel G, Mendlewicz J. Neuropsychobiology; 1981 Jun 17; 7(3):137-51. PubMed ID: 6164951 [Abstract] [Full Text] [Related]
13. CSF amine metabolites and depression. Peabody CA, Faull KF, King RJ, Whiteford HA, Barchas JD, Berger PA. Psychiatry Res; 1987 May 17; 21(1):1-7. PubMed ID: 2440071 [Abstract] [Full Text] [Related]
14. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients. Nordin C. Acta Psychiatr Scand; 1988 Dec 17; 78(6):720-9. PubMed ID: 2464903 [Abstract] [Full Text] [Related]
15. CSF-amine metabolites in depression, dementia and in controls. Gjerris A, Werdelin L, Gjerris F, Sørensen PS, Rafaelsen OJ, Alling C. Acta Psychiatr Scand; 1987 Jun 17; 75(6):619-28. PubMed ID: 2441573 [Abstract] [Full Text] [Related]
16. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers. De Bellis MD, Geracioti TD, Altemus M, Kling MA. Biol Psychiatry; 1987 Jun 17; 33(8-9):636-41. PubMed ID: 7687151 [Abstract] [Full Text] [Related]
17. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid. Blennow K, Wallin A, Gottfries CG, Månsson JE, Svennerholm L. J Neural Transm Park Dis Dement Sect; 1993 Jun 17; 5(1):5-15. PubMed ID: 7679905 [Abstract] [Full Text] [Related]
18. The effect of valproic acid on the 5-hydroxyindoleacetic, homovanillic and lactic acid levels of cerebrospinal fluid. MacMillan V, Leake J, Chung T, Bovell M. Brain Res; 1987 Sep 15; 420(2):268-76. PubMed ID: 2445434 [Abstract] [Full Text] [Related]
19. Lateral ventricle-brain ratio and balance between CSF HVA and 5-HIAA in schizophrenia. Lewine RR, Risch SC, Risby E, Stipetic M, Jewart RD, Eccard M, Caudle J, Pollard W. Am J Psychiatry; 1991 Sep 15; 148(9):1189-94. PubMed ID: 1715677 [Abstract] [Full Text] [Related]
20. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease. Blennow K, Wallin A, Gottfries CG, Lekman A, Karlsson I, Skoog I, Svennerholm L. Neurobiol Aging; 1992 Sep 15; 13(1):107-13. PubMed ID: 1371850 [Abstract] [Full Text] [Related] Page: [Next] [New Search]